-
EP2125748
European procedure
Extract from the Register of European Patents
EP About this file: EP2125748
| EP2125748 - ACYLAMINOPYRAZOLES AS FGFR INHIBITORS [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 30.03.2012 Database last updated on 11.04.2026 | Most recent event Tooltip | 30.03.2012 | No opposition filed within time limit | published on 02.05.2012 [2012/18] | Applicant(s) | For all designated states AstraZeneca AB 151 85 Södertälje / SE | [2009/49] | Inventor(s) | 01 /
FOOTE, Kevin Michael AstraZeneca R & D Alderley Alderley Park Macclesfield Cheshire SK10 4TG / GB | 02 /
THEOCLITOU, Maria-Elena AstraZeneca R & D Alderley Alderley Park Macclesfield Cheshire SK10 4TG / GB | 03 /
THOMAS, Andrew Peter AstraZeneca R & D Alderley Alderley Park Macclesfield Cheshire SK10 4TG / GB | 04 /
BUTTAR, David AstraZeneca R & D Alderley Alderley Park Macclesfield Cheshire SK10 4TG / GB | [2009/49] | Application number, filing date | 07848646.1 | 20.12.2007 | [2009/49] | WO2007GB04917 | Priority number, date | US20060871190P | 21.12.2006 Original published format: US 871190 P | US20070985542P | 05.11.2007 Original published format: US 985542 P | [2009/49] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2008075068 | Date: | 26.06.2008 | Language: | EN | [2008/26] | Type: | A2 Application without search report | No.: | EP2125748 | Date: | 02.12.2009 | Language: | EN | The application published by WIPO in one of the EPO official languages on 26.06.2008 takes the place of the publication of the European patent application. | [2009/49] | Type: | B1 Patent specification | No.: | EP2125748 | Date: | 25.05.2011 | Language: | EN | [2011/21] | Search report(s) | International search report - published on: | EP | 02.10.2008 | Classification | IPC: | C07D231/40, C07D401/06, C07D401/12, C07D401/14, C07D403/12, C07D405/06, C07D409/12, C07D413/12, C07D471/04, C07D487/04, A61K31/415, A61P35/00 | [2009/49] | CPC: |
C07D231/40 (EP,NO,US);
C07D471/04 (EP,KR,NO,US);
A61K31/415 (KR,NO);
A61P35/00 (EP,NO);
A61P35/02 (EP);
A61P43/00 (EP);
C07D401/06 (EP,US);
C07D401/12 (EP,NO,US);
C07D401/14 (EP,US);
C07D403/12 (EP,NO,US);
C07D405/06 (EP,NO,US);
C07D405/12 (EP,US);
C07D409/12 (EP,KR,NO,US);
C07D409/14 (EP,US);
C07D413/12 (EP,NO,US);
C07D487/04 (EP,NO,US)
(-)
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, PL, PT, RO, SE, SI, SK, TR [2009/49] | Extension states | AL | 21.07.2009 | BA | 21.07.2009 | HR | 21.07.2009 | MK | 21.07.2009 | RS | 21.07.2009 | Title | German: | ACYLAMINOPYRAZOLE ALS FGFR-INHIBITOREN | [2009/49] | English: | ACYLAMINOPYRAZOLES AS FGFR INHIBITORS | [2009/49] | French: | ACYLAMINOPYRAZOLES COMME INHIBITEURS DE FGFR | [2009/49] | Entry into regional phase | 21.07.2009 | National basic fee paid | 21.07.2009 | Designation fee(s) paid | 21.07.2009 | Examination fee paid | Examination procedure | 25.06.2009 | Amendment by applicant (claims and/or description) | 21.07.2009 | Examination requested [2009/49] | 19.02.2010 | Communication of intention to grant the patent | 28.05.2010 | Fee for grant paid | 28.05.2010 | Fee for publishing/printing paid | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 19.02.2010 | Opposition(s) | 28.02.2012 | No opposition filed within time limit [2012/18] | Fees paid | Renewal fee | 04.01.2010 | Renewal fee patent year 03 | 03.01.2011 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [A] US2005209297 (SANNER MARK A et al.) [A] 1-27 * claims 1-20 * | [A] WO2005051919 (PFIZER PROD INC et al.) [A] 1-27 * claims 1-10 * | [A] WO2005048948 (AMBIT BIOSCIENCES CORP et al.) [A] 1-27 * claims 1-75 * | [A] WO2005105780 (VERTEX PHARMA et al.) [A] 1-27 * claims 1-27 * | [A] C. N. CAVASOTTO ET AL.: "In silico identification of novel EGFR inhibitors with antiproliferative activity against cancer cells", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, vol. 16, 18 January 2006 (2006-01-18), pages 1969 - 1974, XP002487848 [A] 1-27 * Compound 41 *;; table 1 * DOI: http://dx.doi.org/10.1016/j.bmcl.2005.12.067 |